Filter
2221
Filtered Results: 2221
Text search:
medicines
financing
Featured
Recommendations
158
New Publications
702
Language
Document type
No document type
1281
Studies & Reports
472
Guidelines
168
Strategic & Response Plan
147
Manuals
94
Fact sheets
22
Situation Updates
15
Training Material
12
Infographics
5
Resource Platforms
4
Brochures
1
Countries / Regions
Global
131
Kenya
96
Sierra Leone
57
Uganda
56
Ethiopia
53
Western and Central Europe
50
India
50
Liberia
49
Nigeria
48
Africa
47
Zambia
42
Ghana
41
Malawi
41
Myanmar / Burma
41
Nepal
39
Ukraine
38
Bangladesh
37
Rwanda
36
South Africa
36
Latin America and the Carribbean
33
Tanzania
31
Eastern Europe
29
Asia
21
Namibia
21
South–East Asia Region
18
Zimbabwe
16
Philippines
16
Mozambique
16
East and Southern Africa
16
Cambodia
15
Lesotho
14
Syria
13
Senegal
13
Congo, Democratic Republic of
13
Botswana
13
Indonesia
13
Guinea
12
Haiti
12
West and Central Africa
12
Middle East and North Africa
10
Cameroon
9
Venezuela
8
Eastern Europe and Central Asia
8
Russia
8
Eswatini/ Swaziland
8
Pakistan
8
Benin
7
Burkina Faso
7
Afghanistan
6
Paraguay
6
Moldova
6
Sudan
6
Tajikistan
5
Western Pacific Region
5
North America
5
Yemen
5
Georgia
5
South Sudan
5
Somalia
5
North Macedonia
4
Thailand
4
Laos
4
Jordan
4
Germany
4
Vietnam
4
Gambia
3
Albania
3
Peru
3
Lebanon
3
Brazil
3
Ecuador
3
Turkey
2
China
2
Kazakhstan
2
Chile
2
Iran
2
Kyrgyzstan
2
Qatar
2
Jamaica
2
Southern Africa
2
Bolivia
2
Sri Lanka
2
Egypt
2
Palestine
2
Central African Republic
2
Libya
2
Colombia
1
Timor Leste/ East Timor
1
Niger
1
Uzbekistan
1
Mongolia
1
Bulgaria
1
Armenia
1
USA
1
Lithuania
1
Saudi Arabia
1
Turkmenistan
1
Japan
1
Belgium
1
Mauritius
1
Bosnia and Herzegovina
1
Papua New Guinea
1
Djibouti
1
Mali
1
Chad
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
959
Public Health
158
Clinical Guidelines
109
Key Resources
98
Women & Child Health
88
Pharmacy & Technologies
14
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
HIV
183
TB
171
COVID-19
138
Mental Health
107
Health Financing Toolbox
84
Planetary Health
77
AMR
73
Global Health Education
72
Disability
53
Caregiver
52
Pharmacy
47
Conflict
47
Rapid Response
45
NCDs
39
Ebola & Marburg
37
NTDs
35
Refugee
23
Natural Hazards
22
Cholera
8
Polio
8
Social Ethics
4
Malaria
4
Zika
3
Specific Hazards
2
IHME’s Financing Global Health report provides an overview of health spending around the world, with a special focus on investments in health in low- and middle-income countries. The report examines how this funding for health is changing each year and forecasts how it may change in the future. Fi...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
The majority of developing countries will fail to achieve their targets for Universal Health Coverage (UHC)1 and the health- and poverty-related Sustainable Development Goals (SDGs) unless they take urgent steps to strengthen their health financing. Just over a decade out from the SDG deadline of 20...
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
Africa is off track to reach the Sustainable Development Goals by 2030 and lags behind in building resilient health systems
and health security, against a backdrop of limited resources. The world envisaged a significant role for governments
in funding the Sustainable Development Agenda, but inadeq...
Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t...
The world has been turned on its head by the coronavirus disease 2019 (COVID-19) pandemic. This has provided a stark wakeup call on the severe under-financing of health systems around the world. It has laid bare the inequalities and limitations in the capacities of countries at all levels of develop...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
This policy paper outlines key health financing policy actions for countries to ensure universal access to health services and financial protection for people fleeing conflict. It focuses on three policy areas – granting entitlement and ensure access to the full range of needed health services for...
The product of all this work is the Standard Treatment Guideline and Essential Medicines List of Common Medical Conditions in the Kingdom of Swaziland. These systematically developed statements are designed to assist practitioners in making decisions about appropriate treatment for specific clinical...
Financing Global Health 2016: Development Assistance, Public and Private Health Spending for the Pursuit of Universal Health Coverage presents a complete analysis of the resources available for health in 184 countries, with a particular focus on development assistance for health (DAH). DAH was estim...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect ...
During this work, a survey on essential medicines availability was conducted. This article was first written on this subject for sharing the poor financial availability of the essential medicines in the hospital and secondly, a call for an action to be taken in improving hospital pharmacies developm...
Annual and medium-term budget preparation processes are the platforms through which specific plans are transformed into actual resource allocation decisions. The aim of this Process Guide is to support key stakeholders involved in these processes (such as the Cabinet, Ministries of Finance and Healt...
Prices people pay for medicines.
